The SPAC in its latest filing included an investor presentation on its proposed merger with Playboy. The deal is valued at about $381 million. Read more.
Related Posts
Locust Walk Upsizes IPO 18% to $153M
The SPAC is focusing on the healthcare sector or healthcare-related industries in the United States and Europe, especially companies in the life sciences sector.
OceanTech Acquisitions I and Captura Biopharma Merging in $224M Deal
Captura is developing and commercializing oral chelators to treat internal radiation contamination and heavy metal poisoning. A chelate is a bonding of ions and molecules to metal ions.
Lux Health Tech Slates Shareholder Vote on Deadline Extension
Lux Health earlier this month said it entered into a non-binding letter of intent for a business combination with an unnamed life sciences company.
8i Acquisition 2 Enters FPA with Greentree Financial Group
Greentree may sell its 120,000 shares to the SPAC after 8i closes a merger with health platform EUDA.